Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neurotoxicity Syndromes × Trastuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 208 Stomach Neoplasms 17 Neoplasm Metastasis 13 Breast Neoplasms, Male 13 Neoplasms 8 Esophageal Neoplasms 8 Brain Neoplasms 7 Inflammatory Breast Neoplasms 6 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Triple Negative Breast Neoplasms 3 Urologic Neoplasms 2 HER2-positive Breast Cancer 2 Gallbladder Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Rectal Neoplasms 1 Patient Preference 1 Patient Compliance 1 Osteitis Deformans 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Locally Advanced Breast Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Hormone Receptor Positive Breast Cancer 1

Interventions

Taxes 2 Paclitaxel 2 Carboplatin 2 haloperidol decanoate 1 glutamic acid diethyl ester 1 axicabtagene ciloleucel 1 Vitamin E 1 Vincristine 1 Thalidomide 1 Surveys and Questionnaires 1 Rituximab 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiosurgery 1 Procarbazine 1 Peripheral Blood Stem Cell Transplantation 1 Pain Management 1 Oxaliplatin 1 Modafinil 1 Methotrexate 1 Memantine 1 Melphalan 1 Magnesium Sulfate 1 Lorazepam 1 Leucovorin 1 Lamotrigine 1 Ketamine 1 Interleukin 1 Receptor Antagonist Protein 1 In Situ Hybridization, Fluorescence 1 Glutathione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡